Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Stipp

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Biological Chemistry|December 11, 2012
Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancerAlison K Esser, Michael R Miller, Qin Huang, et al.
JCI Insight|September 6, 2022
PRC2 loss drives MPNST metastasis and matrix remodelingQierra R Brockman, Amanda Scherer, Gavin R McGivney, et al.
Cancer Research|August 17, 2019
Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human MelanomaCharlotte R Feddersen, Jacob L Schillo, Afshin Varzavand, et al.
Oncogene|October 18, 2025
A critical role of FAK signaling in Rac1-driven melanoma cell resistance to MAPK pathway inhibitionJesse D Riordan, Teagan A Nathanson, Afshin Varzavand, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
A critical role of FAK signaling in Rac1-driven melanoma cell resistance to MAPK pathway inhibitionJesse D Riordan, Teagan A Nathanson, Afshin Varzavand, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasisXinyu Deng, Qinglin Li, John Hoff, et al.
Oncotarget|April 30, 2016
TAZ and YAP are frequently activated oncoproteins in sarcomasColleen A Fullenkamp, Sarah L Hall, Omar I Jaber, et al.
Cell Death Discovery|June 20, 2026
Newly identified invasion drivers define the tumor front in oral squamous cell carcinomaGuillermo Flores, Slyn Uaroon, Juan A R Garay, et al.
Circulation Research|April 1, 2024
CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular InflammationJunxiong Chen, Yingjun Ding, Chao Jiang, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Biological Chemistry|December 11, 2012
Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancerAlison K Esser, Michael R Miller, Qin Huang, et al.
JCI Insight|September 6, 2022
PRC2 loss drives MPNST metastasis and matrix remodelingQierra R Brockman, Amanda Scherer, Gavin R McGivney, et al.
Cancer Research|August 17, 2019
Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human MelanomaCharlotte R Feddersen, Jacob L Schillo, Afshin Varzavand, et al.
Oncogene|October 18, 2025
A critical role of FAK signaling in Rac1-driven melanoma cell resistance to MAPK pathway inhibitionJesse D Riordan, Teagan A Nathanson, Afshin Varzavand, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
A critical role of FAK signaling in Rac1-driven melanoma cell resistance to MAPK pathway inhibitionJesse D Riordan, Teagan A Nathanson, Afshin Varzavand, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasisXinyu Deng, Qinglin Li, John Hoff, et al.
Oncotarget|April 30, 2016
TAZ and YAP are frequently activated oncoproteins in sarcomasColleen A Fullenkamp, Sarah L Hall, Omar I Jaber, et al.
Cell Death Discovery|June 20, 2026
Newly identified invasion drivers define the tumor front in oral squamous cell carcinomaGuillermo Flores, Slyn Uaroon, Juan A R Garay, et al.
Circulation Research|April 1, 2024
CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular InflammationJunxiong Chen, Yingjun Ding, Chao Jiang, et al.
Pageof 4